ZyVersa
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ZyVersa and buy or sell other stocks, ETFs, and their options commission-free!About ZVSA
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It leverages advanced & proprietary technologies to develop product candidates in the areas of renal and inflammatory diseases.
CEOStephen C. Glover
CEOStephen C. Glover
Employees14
Employees14
HeadquartersWeston, Florida
HeadquartersWeston, Florida
Founded2014
Founded2014
Employees14
Employees14
ZVSA Key Statistics
Market cap13.55M
Market cap13.55M
Price-Earnings ratio-0.37
Price-Earnings ratio-0.37
Dividend yield—
Dividend yield—
Average volume3.39M
Average volume3.39M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$523.25
52 Week high$523.25
52 Week low$1.89
52 Week low$1.89
Stock Snapshot
The current ZyVersa(ZVSA) stock price is $0.31, with a market capitalization of 13.55M. The stock trades at a price-to-earnings (P/E) ratio of -0.37.
On 2025-12-14, ZyVersa(ZVSA) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 3.39M.
Over the past 52 weeks, ZyVersa(ZVSA) stock has traded between a high of $523.25 and a low of $1.89.
Over the past 52 weeks, ZyVersa(ZVSA) stock has traded between a high of $523.25 and a low of $1.89.
People also own
Based on the portfolios of people who own ZVSA. This list is generated using Robinhood data, and it’s not a recommendation.